Le Lézard
Classified in: Health
Subjects: MAV, VET, FVT

Media Advisory - Announcement - Minister of Veterans Affairs, Seamus O'Regan, will make an important announcement regarding Veterans' mental health


OTTAWA, May 3, 2018 /CNW/ - The Honourable Seamus O'Regan, Minister of Veterans Affairs and Associate Minister of National Defence, will help kick off the Canadian Mental Health Association's mental health week with an important announcement from Veterans Affairs Canada. The announcement will be followed by a dynamic panel discussion moderated by Minister O'Regan and will feature mental health professionals from Veterans Affairs Canada, the Canadian Armed Forces and The Royal.

Minister O'Regan, as well as other event participants, will be available to media and for a photo opportunity following the announcement.

This event will also be aired live on Facebook on Veterans Affairs Canada's official page.

Please note that this advisory is subject to change without notice.

 

Location:

Royal Ottawa Mental Health Centre

Winter Garden (2nd floor)

1145 Carling Ave

Ottawa, ON

Date: 

Monday, May 7, 2018

Time:

10:00 a.m. EDT

 

SOURCE Veterans Affairs Canada


These press releases may also interest you

at 02:15
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

at 01:00
Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024
REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and the extraordinary shareholders'...

at 00:16
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA...

at 00:00
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101...

More news about Health...


News published on and distributed by: